1. Home
  2. GNPX vs FGI Comparison

GNPX vs FGI Comparison

Compare GNPX & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • FGI
  • Stock Information
  • Founded
  • GNPX 2009
  • FGI 1987
  • Country
  • GNPX United States
  • FGI United States
  • Employees
  • GNPX N/A
  • FGI N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • FGI Industrial Specialties
  • Sector
  • GNPX Health Care
  • FGI Industrials
  • Exchange
  • GNPX Nasdaq
  • FGI Nasdaq
  • Market Cap
  • GNPX 6.1M
  • FGI 7.2M
  • IPO Year
  • GNPX 2018
  • FGI 2022
  • Fundamental
  • Price
  • GNPX $0.38
  • FGI $0.67
  • Analyst Decision
  • GNPX Strong Buy
  • FGI
  • Analyst Count
  • GNPX 1
  • FGI 0
  • Target Price
  • GNPX $10.00
  • FGI N/A
  • AVG Volume (30 Days)
  • GNPX 6.0M
  • FGI 7.6K
  • Earning Date
  • GNPX 05-13-2025
  • FGI 03-26-2025
  • Dividend Yield
  • GNPX N/A
  • FGI N/A
  • EPS Growth
  • GNPX N/A
  • FGI N/A
  • EPS
  • GNPX N/A
  • FGI N/A
  • Revenue
  • GNPX N/A
  • FGI $131,818,073.00
  • Revenue This Year
  • GNPX N/A
  • FGI $11.39
  • Revenue Next Year
  • GNPX N/A
  • FGI $6.26
  • P/E Ratio
  • GNPX N/A
  • FGI N/A
  • Revenue Growth
  • GNPX N/A
  • FGI 12.43
  • 52 Week Low
  • GNPX $0.22
  • FGI $0.70
  • 52 Week High
  • GNPX $4.09
  • FGI $1.59
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 43.09
  • FGI 36.16
  • Support Level
  • GNPX $0.22
  • FGI $0.84
  • Resistance Level
  • GNPX $0.39
  • FGI $0.86
  • Average True Range (ATR)
  • GNPX 0.06
  • FGI 0.04
  • MACD
  • GNPX 0.00
  • FGI -0.01
  • Stochastic Oscillator
  • GNPX 31.23
  • FGI 0.00

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.

Share on Social Networks: